Related Experiment Video
Updated: Oct 4, 2025
08:50
Easy Manipulation of Architectures in Protein-based Hydrogels for Cell Culture Applications
Published on: August 4, 2017
6.9K
Programmable DNA Hydrogels as Artificial Extracellular Matrix
Yuhan Wei1, Kaizhe Wang1, Shihua Luo2
1School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P. R. China.
Small (Weinheim an Der Bergstrasse, Germany)
|February 4, 2022
Summary
Programmable DNA hydrogels mimic the natural extracellular matrix (ECM) for cell applications. These advanced materials offer precise structural control for cell encapsulation, culture, and tissue engineering.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Molecular Engineering
Background:
- The cell microenvironment, particularly the extracellular matrix (ECM), critically influences cell behavior and fate.
- Hydrogels are widely used to mimic the ECM's physical and chemical cues.
- DNA hydrogels offer unique programmable capabilities for precise structural customization.
Purpose of the Study:
- To review recent advances in programmable DNA hydrogels as artificial extracellular matrices.
- To focus on pure DNA hydrogels and their applications.
- To discuss challenges and future prospects for cellular applications.
Main Methods:
- Classification and design principles of DNA hydrogels.
- Assembly strategies for creating DNA hydrogel structures.
- Review of state-of-the-art achievements in cellular applications.
Main Results:
- DNA hydrogels provide tunable properties and precise structural customization.
- Successful applications demonstrated in cell encapsulation and culture.
- Significant progress in tissue engineering using DNA hydrogels.
Conclusions:
- Programmable DNA hydrogels represent a promising biomaterial for mimicking the ECM.
- Further research is needed to overcome challenges in cellular applications.
- DNA hydrogels hold great potential for advancing regenerative medicine and cell-based therapies.
